Styrenix Performance Materials Ltd
Styrenix Performance Materials Q3 FY26 earnings call: Revenue & Margins
Q3 FY26 earnings call: what management said on revenue, margins and capex.
Guidance rank: #68 of 68 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
The short version
Styrenix expects medium- to long-term sales growth in Thailand as customer validations complete, especially in EV, premium electronics, household appliances, and medical device segments (Page 19). Capacity expansions underway, particularly Phase 1 ABS expansion expected to start in FY 27 and ramp up in coming quarters.
From Styrenix Performance Materials Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Styrenix expects medium- to long-term sales growth in Thailand as customer validations complete, especially in EV, premium electronics, household appliances, and medical device segments (Page 19).
- In India, volume growth is seen due to capacity expansions, such as polystyrene capacity increased from ~65,000-70,000 tons to ~100,000 tons, focused on GPPS (Page 19, 9).
- ABS capacity expansions are underway, with management expecting to start Phase 1 ABS expansion in FY27 and aiming for higher utilization in FY28 (Page 11).
- Despite new capacities coming up, Styrenix anticipates sufficient market demand with India remaining a net importer; volume growth opportunities therefore exist (Page 10).
2 more points from Styrenix Performance Materials Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Styrenix Performance Materials Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Capex for Phase 1 expansion is approximately INR 350 crores, expected to spill over FY 2026 and FY 2027.
- Phase 1 of ABS expansion is planned to start in FY 2027, with equipment ordering and construction on track.
- Phase 1 completion is targeted by H2 of FY 2027.
- Phase 2 expansion will begin post Phase 1 completion, potentially in the following financial year.
- The company plans to finance capex through internal accruals and possibly a capex loan (not yet taken).
- No significant deviation or update on the capex timeline as of now.
2 more points from Styrenix Performance Materials Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Styrenix Performance Materials Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Styrenix Performance Materials Ltd said on order book & pipeline — free account, 30 seconds.
Styrenix Performance Materials Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹994 Cr, net profit ₹23 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Styrenix Perfor.'s management said in earlier quarters
- Q2 FY27 earnings call analysis →
- Q1 FY27 earnings call analysis →
- Q1 FY26 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q4 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
- Q4 FY23 earnings call →
Others in Chemicals & Petrochemicals this season
- Neochem Bio (Q3 FY26)
Revenue for Q2 FY26 (Sept’25) stood at ₹4,583.16 Lakh. Key investor presentation takeaways from Neochem Bio Solutions Ltd's Q3 FY26 investor presentation — and
- Thirumalai Chem. (Q3 FY26)
Q3 FY26 Revenue from Operations (INR Cr):** . Key investor presentation takeaways from Thirumalai Chemicals Ltd's Q3 FY26 investor presentation — and how it ran
- IVP (Q3 FY26)
Q3 FY26 Revenue from Operations: ₹144.97 crore . Key investor presentation takeaways from IVP's Q3 FY26 investor presentation — and how it ranks against sector
- Gujarat Alkalies (Q3 FY26)
3,144.48 Crores, down from Rs. Key investor presentation takeaways from Gujarat Alkalies & Chemicals Ltd's Q3 FY26 investor presentation — and how it ranks agai
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Styrenix Performance Materials Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Styrenix Performance Materials Ltd Q3 FY26 results?
Styrenix expects medium- to long-term sales growth in Thailand as customer validations complete, especially in EV, premium electronics, household appliances, and medical device segments (Page 19). Capacity expansions underway, particularly Phase 1 ABS expansion expected to start in FY 27 and ramp up in coming quarters.
What is Styrenix Performance Materials Ltd share price analysis?
Styrenix Performance Materials Ltd currently shows a neutral. The stock trades at a P/E of 14.0 with a market cap of ₹3,841 Cr. Investors should review the full earnings analysis for detailed insights.
Is Styrenix Performance Materials Ltd planning capital expenditure?
Capex for Phase 1 expansion is approximately INR 350 crores, expected to spill over FY 2026 and FY 2027.
Keep Styrenix Performance Materials Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
